supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago
Research Papers that Mention the Interaction
“RESULTS In … patients, du ilumab 20 0 and 300 mg every 2 weeks vs matched placebo reduced severe asthma exacerbation rates by 44% (P = ….33) and 75% (P = 0.03), respectively, and improved FEV1 at Week 12 by 0.20 L ( P = 0.05) and 0.17 L (P = 0.12).”
Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study.
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback